Breast cancer drug developed by UB professor moves closer to clinical trials

Published October 24, 2017

WBFO-FM reports on For-Robin, a UB startup company that is showing strong progress in developing a new and effective cancer treatment that it hopes to begin testing in humans. In the story, Kate Rittenhouse-Olson, professor emeritus of biotechnical and clinical laboratory sciences and the founder for For-Robin, said, “We want to give each person the time to fulfill their promise, I think. So if we could help the young women with this triple-negative form fight their cancer, add one more thing to help them fight their cancer, it would be great."

Read more:

Media Contact Information

Media Relations (University Communications)
330 Crofts Hall (North Campus)
Buffalo, NY 14260-7015
Tel: 716-645-6969
Fax: 716-645-3765